{"status": "ok", "totalResults": 11, "articles": [{"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "BBC News"}, "author": null, "title": "Type 1 diabetes: breakthrough treatment could be offered in NI - BBC.com", "description": "Health officials say they will need more money before they can offer the devices  in Northern Ireland.", "url": "https://www.bbc.com/news/articles/c3g440nv0g5o", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/fd75/live/94110280-f1c8-11ee-b5f4-cbdd9c871d87.jpg", "publishedAt": "2024-04-03T15:47:09Z", "content": null}, {"source": {"id": null, "name": "Modernatx.com"}, "author": null, "title": "Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature - Moderna Investor Relations", "description": "CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that interim data for a first-in-human, phase 1/2, open-label, dose optimization study and extension study, evaluating the safety and efficacy of mRNA-3927, an investigat\u2026", "url": "https://investors.modernatx.com/news/news-details/2024/Phase-12-Interim-Data-on-Modernas-mRNA-3927-an-Investigational-mRNA-Therapy-for-Propionic-Acidemia-Published-in-Nature/default.aspx", "urlToImage": null, "publishedAt": "2024-04-03T15:08:13Z", "content": "CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that interim data for a first-in-human, phase 1/2, open-label, dose optimization study and extension study, ev\u2026 [+7207 chars]"}, {"source": {"id": null, "name": "Gbnews.com"}, "author": "Adam Chapman", "title": "B12-deficiency symptoms can be permanent, warns one sufferer - GB News", "description": "B12 deficiency can cause a spate of unpleasant symptoms. Injections can help attenuate its impact but the damage can be permanent", "url": "https://www.gbnews.com/health/b12-deficiency-symptoms-injections", "urlToImage": "https://www.gbnews.com/media-library/person-scrunching-up-their-toes.jpg?id=51908033&width=1200&height=600&coordinates=0%2C500%2C0%2C500", "publishedAt": "2024-04-03T14:13:23Z", "content": "Have you heard of B12 deficiency? You may be vaguely aware of it but have no understanding of its impact. \r\nIf that's the case, you are one of the lucky ones. \r\nA person has taken to Reddit to reveal\u2026 [+2647 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "The Conversation Africa"}, "author": "Barbara Jacquelyn Sahakian, Christelle Langley, Jianfeng Feng, Wei Cheng", "title": "How food preferences are linked to cognition and brain health \u2013 and why a balanced diet is superior - The Conversation", "description": "Vegetarian and low-carb diets aren\u2019t ideal for our brains.", "url": "https://theconversation.com/how-food-preferences-are-linked-to-cognition-and-brain-health-and-why-a-balanced-diet-is-superior-226979", "urlToImage": "https://images.theconversation.com/files/585585/original/file-20240402-16-m9z3f.jpg?ixlib=rb-1.1.0&rect=0%2C454%2C5144%2C2572&q=45&auto=format&w=1356&h=668&fit=crop", "publishedAt": "2024-04-03T11:15:04Z", "content": "From the crispy crunch of fresh veggies to the creamy indulgence of decadent desserts, we all have different food preferences. Our palates develop uniquely, shaped by genetics, culture and personal e\u2026 [+6296 chars]"}, {"source": {"id": null, "name": "Interesting Engineering"}, "author": "Mrigakshi Dixit", "title": "Groundbreaking trial to grow \u2018mini liver\u2019 from patient\u2019s own lymph node - Interesting Engineering", "description": "The formation of the new liver-like organ in the lymph node may take several months.", "url": "https://interestingengineering.com/science/cell-therapy-turns-lymph-node-into-liver", "urlToImage": "https://cms.interestingengineering.com/wp-content/uploads/2024/04/img_6378.jpg", "publishedAt": "2024-04-03T10:33:00Z", "content": "The lymph nodes then act as in vivo bioreactors, helping the hepatocytes to engraft, proliferate, and generate functional ectopic liver tissue, the press release noted.\u00a0\r\nIn simplest terms, these cel\u2026 [+832 chars]"}, {"source": {"id": null, "name": "ScienceAlert"}, "author": "David Nield", "title": "'Ozempic Babies' \u2013 Just TikTok Hype or Does It Interfere With Birth Control? - ScienceAlert", "description": "Medications like Wegovy and Ozempic have been promoted in recent years for their potential health benefits, not least of all as a way to help control appetite.", "url": "https://www.sciencealert.com/ozempic-babies-just-tiktok-hype-or-does-it-interfere-with-birth-control", "urlToImage": "https://www.sciencealert.com/images/2024/03/BirthControl.jpg", "publishedAt": "2024-04-03T00:36:04Z", "content": "Medications like Wegovy and Ozempic have been promoted in recent years for their potential health benefits, not least of all as a way to help control appetite.\r\nYet recently, they've been hitting the\u2026 [+2375 chars]"}]}